Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.

Krum H, Mohacsi P, Katus HA, Tendera M, Rouleau JL, Fowler MB, Coats AJ, Roecker EB, Packer M; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group..

Am Heart J. 2006 Jan;151(1):55-61.

PMID:
16368292
2.

Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.

Stewart S, McMurray JJ, Hebborn A, Coats AJ, Packer M; COPERNICUS Study Group..

Int J Cardiol. 2005 Apr 8;100(1):143-9.

PMID:
15820297
3.

Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.

Deedwania PC, Giles TD, Klibaner M, Ghali JK, Herlitz J, Hildebrandt P, Kjekshus J, Spinar J, Vitovec J, Stanbrook H, Wikstrand J; MERIT-HF Study Group..

Am Heart J. 2005 Jan;149(1):159-67.

PMID:
15660048
4.

Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.

Rouleau JL, Roecker EB, Tendera M, Mohacsi P, Krum H, Katus HA, Fowler MB, Coats AJ, Castaigne A, Scherhag A, Holcslaw TL, Packer M; Carvedilol Prospective Randomized Cumulative Survival Study Group..

J Am Coll Cardiol. 2004 Apr 21;43(8):1423-9.

5.

Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.

Krum H, Roecker EB, Mohacsi P, Rouleau JL, Tendera M, Coats AJ, Katus HA, Fowler MB, Packer M; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group..

JAMA. 2003 Feb 12;289(6):712-8.

PMID:
12585949
6.

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Staiger C, Holcslaw TL, Amann-Zalan I, DeMets DL; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group..

Circulation. 2002 Oct 22;106(17):2194-9.

7.

Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).

Ghali JK, PiƱa IL, Gottlieb SS, Deedwania PC, Wikstrand JC; MERIT-HF Study Group..

Circulation. 2002 Apr 2;105(13):1585-91.

8.

Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.

Wedel H, Demets D, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F, Wikstrand J; MERIT-HF Study Group..

Am Heart J. 2001 Sep;142(3):502-11.

PMID:
11526365

Supplemental Content

Loading ...
Support Center